Short interest for Cooper Companies gives investors a sense of the degree to which investors are betting on the decline of Cooper Companies's stock. Short interest data is updated every two weeks.

Cooper Companies Stock (NASDAQ:COO), Short Interest Report

Cooper Companies

The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

S&P500

Equities

Large Cap

Broad U.S. Equity ETFs

Markets

Tech

ETFs

AMAT

AVGO

CTLT

DXCM

JNPR

NTAP

NVDA

TSLA

UBER

U.S. stock market continues bull run, hitting record highs for S&amp;P 500 and Nasdaq 100. SPY ETF surpasses $500 billion AUM, with other companies also reaching milestones.

Record-High S&amp;P 500 Propels SPY ETF To $500-Billion Milestone, Nvidia Tops $2 Trillion, Broadcom Surpasses Tesla

Wall Street bull

Earnings

Mid Cap

News

Asset Sales

Small Cap

Econ #s

Federal Reserve

Intraday Update

AAPL

SPDR Dow Jones Industrial Average ETF Trust

ESTC

MRVL

NYCB

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

March began on a high note on Wall Street, with tech stocks driving indices to record levels. Despite weak data and mixed Fed remarks, investors remain optimistic. Semiconductor industry continues to surge, while NYCB plummets due to internal control weakness. Gold also reaches all-time high. Major indices and tech sector perform well, while utilities lag behind. NetApp and Dominion Energy see significant stock movement.

S&amp;P 500, Nasdaq 100 Hit Record Highs As Dollar, Treasury Yields Weaken, Chipmakers Shine, NYCB Sinks: What&#39;s Driving Markets Friday?

Penny Stocks

Movers

Trading Ideas

ACIC

ADIL

ARVN

BIVI

CRDF

DCFC

DELL

DMTK

DTIL

EVBG

GRTS

HLTH

HUMA

JAGX

JAKK

LIFW

MINM

OPRA

RDNT

REAL

RGNX

RILY

RMBS

ROOT

RPAY

SANA

SCLX

SENS

SIDU

SOUN

TTEC

VANI

VLCN

VTYX

XPOF

YMAB

Shares of  Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.

Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

The Cooper Companies, Inc. - Common Stock

The Cooper Companies Inc

Traeger Inc

Corner Growth Acquisition Corp. - Class A Ordinary Shares

Corner Growth Acquisition Corp

Corner Growth Acquisition Corp. - Warrant

Mr. Cooper Group Inc

Carbios SA

Australian Oilseeds Holdings Limited - Ordinary Shares

Australian Oilseeds Holdings Ltd

Australian Oilseeds Holdings Limited - Warrant

Citigroup analyst Joanne Wuensch maintains Cooper Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>) with a Buy and raises the price target from $108 to $116.

Price Target

Analyst Ratings

Citigroup Maintains Buy on Cooper Companies, Raises Price Target to $116

Agostino Ricupati, SVP &amp; CAO at Cooper Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>), executed a substantial insider sell on March 20, according to an SEC filing.
What Happened: According to a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000711404/000156218024002891//Archives/edgar/data/711404/000156218024002891/0001562180-24-002891-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday, Ricupati sold 54,724 shares of Cooper Companies. The total transaction value is $5,521,230.
The latest market snapshot at Thursday morning reveals Cooper Companies shares down by 0.0%, trading at $101.66.
<h3>Discovering Cooper Companies: A Closer Look</h3>
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.
<h3>Understanding the Numbers: Cooper Companies's Finances</h3>
Revenue Growth: Cooper Companies's revenue growth over a period of 3 months has been noteworthy. As of 31 January, 2024, the company achieved a revenue growth rate of approximately 8.51%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.
Evaluating Earnings Performance:
<ul>
<li>
Gross Margin: The company excels with a remarkable gross margin of 66.96%, indicating superior cost efficiency and profitability compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Cooper Companies's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of 0.41.
</li>
</ul>
Debt Management: Cooper Companies's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.36, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Valuation Overview:
<ul>
<li>
Price to Earnings (P/E) Ratio: A higher-than-average P/E ratio of 69.76 suggests caution, as the stock may be overvalued in the eyes of investors.
</li>
<li>
Price to Sales (P/S) Ratio: With a higher-than-average P/S ratio of 5.53, Cooper Companies's stock is perceived as being overvalued in the market, particularly in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Cooper Companies's EV/EBITDA ratio of 25.54 exceeds industry averages, indicating a premium valuation in the market
</li>
</ul>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
Considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Important Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates grant, award or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000711404">Check Out The Full List Of Cooper Companies's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Insider Transaction: Agostino Ricupati Sells $5.52M Worth Of Cooper Companies Shares

A notable acquisition unfolded on March 20, as Ricupati, SVP &amp; CAO at Cooper Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>), reported the acquisition of stock options for 54,724 shares in an SEC filing.
What Happened: Revealed in a Form 4 filing on Wednesday with the <a href="https://www.sec.gov/Archives/edgar/data/0000711404/000156218024002891//Archives/edgar/data/711404/000156218024002891/0001562180-24-002891-index.htm">U.S. Securities and Exchange Commission</a>, Ricupati, SVP &amp; CAO at Cooper Companies, strategically acquired stock options for 54,724 shares of COO. These options empower Ricupati to buy the company's stock at a favorable exercise price of $69.74 per share.
Currently, Cooper Companies shares are trading down 0.0%, priced at $101.66 during Thursday's morning. This values Ricupati's 54,724 shares at $1,746,924.
<h3>About Cooper Companies</h3>
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.
<h3>Understanding the Numbers: Cooper Companies's Finances</h3>
Revenue Growth: Over the 3 months period, Cooper Companies showcased positive performance, achieving a revenue growth rate of 8.51% as of 31 January, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: Achieving a high gross margin of 66.96%, the company performs well in terms of cost management and profitability within its sector.
</li>
<li>
Earnings per Share (EPS): Cooper Companies's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.41.
</li>
</ul>
Debt Management: Cooper Companies's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.36, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a higher-than-average P/E ratio of 69.76, Cooper Companies's stock is perceived as being overvalued in the market.
</li>
<li>
Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 5.53 as compared to the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Cooper Companies's EV/EBITDA ratio, surpassing industry averages at 25.54, positions it with an above-average valuation in the market.
</li>
</ul>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Uncovering the Importance of Insider Activity</h3>
Emphasizing the importance of a comprehensive approach, considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>Unlocking the Meaning of Transaction Codes</h3>
Delving into transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> typically prioritize those unfolding in the open market, as precisely outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000711404">Check Out The Full List Of Cooper Companies's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Agostino Ricupati Takes A Bullish Stance, Acquiring $1.75M Worth Of Cooper Companies Stock Options

WIIM

Cooper Companies shares are trading higher after Redburn Atlantic upgraded the stock from Neutral to Buy and announced a $125 price target.

Redburn Atlantic analyst Issie Kirby upgrades Cooper Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>) from Neutral to Buy and announces $125 price target.

Upgrades

Redburn Atlantic Upgrades Cooper Companies to Buy, Announces $125 Price Target

JP Morgan upgraded its rating of Cooper Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>) to Overweight with a price target of $120.00, changing its price target from $100.00 to $120.00.
Shares of Cooper Companies are trading up 1.88% over the last 24 hours, at $103.45 per share.
A move to $120.00 would account for a 16.0% increase from the current share price.
<h3>About Cooper Companies</h3>
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.
<h3>About Analyst Ratings</h3>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along with analyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

JP Morgan Upgrades Cooper Companies: Here's What You Need To Know

JP Morgan analyst Robbie Marcus upgrades Cooper Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>) from Neutral to Overweight and raises the price target from $100 to $120.

JP Morgan Upgrades Cooper Companies to Overweight, Raises Price Target to $120

The U.S. stock market continues its unchallenged bull run, with Wall Street notching yet another week of record-breaking highs for the S&amp;P 500 <a href="https://www.benzinga.com/news/earnings/24/03/37427925/s-p-500-nasdaq-100-hit-record-highs-as-dollar-treasury-yields-weaken-chipmakers-shine-nycb-sinks-wh">and Nasdaq 100 indices.</a>
This ongoing surge demonstrates the remarkable strength of the bullish sentiment, with stocks marking their 16th positive week out of the last 18. Since late October, this rally has propelled the S&amp;P 500 index by 25% and the Nasdaq 100 by 30%.
The momentum on Wall Street has also catapulted the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) – the world&#8217;s largest exchange traded fund – to a historic milestone, surpassing $500 billion in assets under management for the first time ever.
Trailing behind the SPY are BlackRock&#8217;s iShares Core S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVV#NYSE">IVV</a>) with $442 billion, and the Vanguard S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NYSE">VOO</a>) with $413 billion under management. 
Other notable milestones were achieved among S&amp;P 500 components during Friday&#8217;s session. Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) reached a market capitalization exceeding $2 trillion, Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) surpassed $700 billion and Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) overtook Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) to become the eighth-most valuable company.
<h2 class="wp-block-heading">Chart: SPY Is First ETF To Reach $500 Billion In AUM</h2>
<img decoding="async" src="https://www.benzinga.com/files/images/story/2024/1709327108_0.png" alt="" />
<h2 class="wp-block-heading">Top-Performing S&amp;P 500 Stocks Friday</h2>
The following are the five top-performing stocks within the S&amp;P 500 on Friday: 
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>Stock Name</th>
<th>Sector</th>
<th>Price</th>
<th>1-Day Return %</th>
</tr>
</thead>
<tbody>
<tr>
<td>NetApp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTAP#NASDAQ">NTAP</a>)</td>
<td>Information Technology</td>
<td>106.93</td>
<td>19.98%</td>
</tr>
<tr>
<td>The Cooper Companies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>)</td>
<td>Health Care</td>
<td>102.07</td>
<td>9.05</td>
</tr>
<tr>
<td>Western Digital Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>)</td>
<td>Information Technology</td>
<td>63.99</td>
<td>7.61</td>
</tr>
<tr>
<td>Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>)</td>
<td>Information Technology</td>
<td>1,392.56</td>
<td>7.08</td>
</tr>
<tr>
<td>DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>)</td>
<td>Health Care</td>
<td>121.19</td>
<td>5.32</td>
</tr>
</tbody>
</table>
</figure>
<h2 class="wp-block-heading">Top 10 Performing S&amp;P 500 Stocks Year-To-Date</h2>
The top-performing S&amp;P 500 stocks year-to-date are as follows:
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Company</td>
<td>YTD Return</td>
<td>Market Cap</td>
</tr>
<tr>
<td>NVIDIA Corporation</td>
<td>65.43%</td>
<td>$2,016B</td>
</tr>
<tr>
<td>Constellation Energy Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>)</td>
<td>44.19%</td>
<td>$53.37B</td>
</tr>
<tr>
<td>Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>)</td>
<td>41.97%</td>
<td>$1,281.15B</td>
</tr>
<tr>
<td>Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>)</td>
<td>36.55%</td>
<td>$325.24B</td>
</tr>
<tr>
<td>Eli Lilly and Company </td>
<td>33.72%</td>
<td>$701.64B</td>
</tr>
<tr>
<td>Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>)</td>
<td>31.30%</td>
<td>$167.86B</td>
</tr>
<tr>
<td>Applied Materials Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>)</td>
<td>29.60%</td>
<td>$174.53B</td>
</tr>
<tr>
<td>Ralph Lauren Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RL#NYSE">RL</a>)</td>
<td>28.68%</td>
<td>$11.86B</td>
</tr>
<tr>
<td>Tapestry, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>)</td>
<td>28.57%</td>
<td>$10.85B</td>
</tr>
<tr>
<td>Catalent, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTLT#NYSE">CTLT</a>)</td>
<td>28.18%</td>
<td>$10.34B</td>
</tr>
</tbody>
</table>
</figure>
Read now: <a href="https://www.benzinga.com/general/biotech/24/02/37408271/top-stocks-not-named-nvidia-you-need-to-know-about-in-2024-heres-what-investors-think-wall-street">Top Stocks Not Named Nvidia You Need To Know About In 2024: Here&#8217;s What Investors Think About Them (Wall Street Vs. Reddit)</a>
Photo via Shutterstock.

Record-High S&P 500 Propels SPY ETF To $500-Billion Milestone, Nvidia Tops $2 Trillion, Broadcom Surpasses Tesla

March kicked off on a high note on Wall Street Friday, with both the S&amp;P 500 and Nasdaq 100 indices soaring to unprecedented heights, fueled by the unstoppable <a href="https://www.benzinga.com/tech">surge of tech stocks.</a>
Despite the sharper-than-expected contraction revealed by the ISM Manufacturing PMI in February – with the overall index plummeting from 49.5 to 47.8, missing the anticipated 49.1 – investors remained upbeat. The data triggered downward pressure on the dollar and Treasury yields, maintaining firm expectations for Federal Reserve rate cuts.
Fed speakers – including Goolsbee, Waller and Bostic – offered a mixed bag of remarks, though collectively acknowledging the ongoing progress toward disinflation. Additionally, a Fed report highlighted that inflation expectations broadly align with the 2% target.
In the tech sector, the semiconductor industry continued its remarkable performance, buoyed by escalating demand for chips associated with artificial intelligence. The industry benchmark, as monitored by the iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>), surged 3.7% following a 2.7% leap on Thursday, marking its highest level since inception. 
Among the Magnificent Seven, Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) underperformed as Goldman Sachs decided to <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37423877/apple-sinks-after-wall-street-titan-pulls-magnificent-7-stock-from-conviction-list">remove the stock from its conviction list</a>, while Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) rose to <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37426167/meta-stock-shatters-records-surges-beyond-500-with-bullish-signals-for-more-upside">fresh record highs above $500</a>. 
New York Community Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYCB#NYSE">NYCB</a>) faces renewed scrutiny after disclosing a &#8220;material weakness&#8221; in its internal controls related to loan review processes, <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37424717/turmoil-at-new-york-community-bancorp-shares-tumble-over-20-triggering-regional-ban">causing shares to plummet by over 20%</a>.
Gold, as tracked by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), is up 2% to $2,085/oz, on track for the strongest session since mid-December and set to close at all-time highs. 
<h2 class="wp-block-heading">Friday&#8217;s Performance In Major US Indices, ETFs</h2>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices </td>
<td>Price</td>
<td>1-Day %Chg</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>18,246.28</td>
<td>1.1%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,076.00</td>
<td>1.1%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,127.19</td>
<td>0.6%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>39,061.76</td>
<td>0.2%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) was 0.7% higher to $511.73, the SPDR Dow Jones Industrial Average (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 0.2% to $390.86 and the tech-heavy Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rose 1.2% to $444.43, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>. 
The Technology Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>), was the outperformer, up by 1.4%, while the Utilities Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) lagged behind, down 1.2%. 
<h2 class="wp-block-heading">Chart of The Day: S&amp;P 500, Nasdaq Jointly Reach All-Time Highs</h2>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="495" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/01142129/image-2-1024x495.png" alt="" class="wp-image-236355" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/01142129/image-2-1024x495.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/01142129/image-2-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/01142129/image-2-768x372.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/01142129/image-2-1536x743.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/01142129/image-2.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h2 class="wp-block-heading">Friday&#8217;s Stock Movers</h2>
<ul>
<li>NetApp Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTAP#NASDAQ">NTAP</a>) rose 22% on stronger-than-expected quarterly results. </li>
<li>Dominion Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>) fell 7%, on track for the largest daily loss since July 2020, after the company forecasted 2024 adjusted earnings below analysts&#8217; estimates.</li>
<li>Spirit AeroSystems Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPR#NYSE">SPR</a>) rallied 13% after reports that Boeing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) is in discussions to buy the supplier. </li>
<li>Friday&#8217;s top-performing chipmakers were Marvell Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>), Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) and Micron Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), with gains between 5% and 7%. </li>
<li>Stocks reacting to earnings were Zscaler Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>), down over 9%, The Cooper Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COO#NYSE">COO</a>), up 9%, MasTec Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTZ#NYSE">MTZ</a>), up 8.5%, NCR Voyix Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VYX#NYSE">VYX</a>), down 18%, Ginkgo Bioworks Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNA#NYSE">DNA</a>), down 15%, Elastic N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>), down 12%. </li>
</ul>
Read now: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37425684/gold-bitcoin-rally-is-us-debt-surge-a-key-driver">Gold, Bitcoin Rally: Is US Debt Surge A Key Driver?</a>
Image created using artificial intelligence via MidJourney.

S&P 500, Nasdaq 100 Hit Record Highs As Dollar, Treasury Yields Weaken, Chipmakers Shine, NYCB Sinks: What's Driving Markets Friday?

Shares of Zscaler, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zs#NASDAQ">ZS</a>) shares fell sharply during Friday&rsquo;s session following second-quarter results.
Zscaler posted better-than-expected earnings and sales results for its second quarter on Thursday. The company said it expects fiscal year 2024 non-GAAP income from operations between $395 million and $400 million and net income per share between $2.73 and $2.77.
Zscaler shares fell 10.1% to $217.43 on Friday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>BioVie Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bivi#NASDAQ">BIVI</a>) shares climbed 96.1% to $2.4319. BioVie&#39;s Ne3107 demonstrated potential improvements in motor and non-motor symptoms for Parkinson&#39;s disease patients and may be realigning physiological processes for Alzheimer&#39;s patients.</li>
<li>Adial Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adil#NASDAQ">ADIL</a>) gained 68.4% to $3.4350. Adial Pharmaceuticals was awarded a new patent covering AD04 for the potential treatment of opioid use disorder.</li>
<li>Cardiff Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crdf#NASDAQ">CRDF</a>) shares rose 41.5% to $2.50 after the company reported better-than-expected fourth-quarter financial results, provided a clinical update on the Phase 2 randomized second-line ONSEMBLE trial in patients with RAS-mutated mCRC and announced the first patient was dosed in the randomized first-line RAS-mutated mCRC trial.</li>
<li>Minim, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/minm#NASDAQ">MINM</a>) shares rose 41.4% to $6.09. On Feb. 20, Minim entered into an employment agreement with David Lazar to engage him as CEO, CFO, following resignation of Jeremy Hitchcock.</li>
<li>The RealReal, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/real#NASDAQ">REAL</a>) gained 39.1% to $2.4613 following upbeat quarterly results.</li>
<li>Nxu, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxu#NASDAQ">NXU</a>) shares gained 36.4% to $1.09 after the company announced it successfully charged a Tesla Cybertruck on Feb. 26.</li>
<li>Jaguar Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jagx#NASDAQ">JAGX</a>) climbed 35.3% to $0.0798.</li>
<li>Dell Technologies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dell#NYSE">DELL</a>) rose 26.3% to $119.52 as the company reported better-than-expected fourth-quarter financial results and increased its annual cash dividend by 20%.</li>
<li>Sweetgreen, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sg#NYSE">SG</a>) gained 26% to $16.05 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>MMTec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) climbed 25% to $1.61.</li>
<li>Everbridge, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evbg#NASDAQ">EVBG</a>) rose 24.5% to $35.19 after it amended and restated the previously announced merger agreement with Thoma Bravo.</li>
<li>NetApp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntap#NASDAQ">NTAP</a>) shares gained 24.4% to $110.85 after the company reported better-than-expected third-quarter financial results and issued guidance.</li>
<li>Xponential Fitness, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xpof#NYSE">XPOF</a>) climbed 24% to $12.50 following strong quarterly sales.</li>
<li>Myomo, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/myo#NYSE">MYO</a>) gained 21.9% to $3.73.</li>
<li>Ventyx Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtyx#NASDAQ">VTYX</a>) climbed 20.1% to $8.50.</li>
<li>MSP Recovery, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lifw#NASDAQ">LIFW</a>) gained 18.8% to $1.01.</li>
<li>Opera Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opra#NASDAQ">OPRA</a>) rose 18.8% to $14.47 following strong sales.</li>
<li>REGENXBIO Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgnx#NASDAQ">RGNX</a>) climbed 18.5% to $20.66.</li>
<li>RadNet, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdnt#NASDAQ">RDNT</a>) gained 18.1% to $44.71 following strong quarterly results.</li>
<li>Sana Biotechnology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sana#NASDAQ">SANA</a>) rose 17.3% to $11.78 after the company reported a year-over-year increase in fourth-quarter financial results.</li>
<li>Tidewater Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tdw#NYSE">TDW</a>) gained 15.3% to $80.73 following fourth-quarter financial results.</li>
<li>Y-mAbs Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ymab#NASDAQ">YMAB</a>) gained 14.3% to $19.09 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Repay Holdings Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rpay#NASDAQ">RPAY</a>) rose 14.4% to $9.94 following upbeat quarterly results.</li>
<li>Root, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/root#NASDAQ">ROOT</a>) gained 14.2% to $36.66. Jefferies analyst Yaron Kinar upgraded Root from Hold to Buy and raised the price target from $10 to $40.</li>
<li>MasTec, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mtz#NYSE">MTZ</a>) rose 11.2% to $83.89 following strong quarterly results.</li>
<li>Rambus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rmbs#NASDAQ">RMBS</a>) gained 9.3% to $64.76. Rambus initiated accelerated share repurchase program to repurchase an aggregate of $50 million of its common stock.</li>
<li>Arvinas, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arvn#NASDAQ">ARVN</a>) rose 9.2% to $50.21. Barclays analyst Peter Lawson maintained Arvinas with an Overweight and raised the price target from $26 to $60.</li>
<li>The Cooper Companies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/coo#NYSE">COO</a>) gained 7.4% to $100.61 after the company reported better-than-expected first-quarter financial results and raised guidance.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>GigCapital5, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gia#NASDAQ">GIA</a>) shares fell 60.7% to $4.35. GigCapital5 announced closing date of March 4, 2024 for business combination with QT Imaging.</li>
<li>Fisker Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsr#NYSE">FSR</a>) shares tumbled 44.6% to $0.4035 after the company reported preliminary fourth-quarter total revenue results below estimates and said it expects to conclude there is substantial doubt about its ability to continue as a going concern when its annual financial statements are filed with the SEC.</li>
<li>Sidus Space, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sidu#NASDAQ">SIDU</a>) fell 39.9% to $5.41. Sidus Space priced public offering 1,321,000 Class A common share at $6 per share.</li>
<li>Scilex Holding Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sclx#NASDAQ">SCLX</a>) shares declined 39.7% to $1.37 after reporting a $10 million bought deal offering.</li>
<li>DermTech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dmtk#NASDAQ">DMTK</a>) fell 32.8% to $0.86 after the company reported worse-than-expected quarterly revenue results.</li>
<li>Precision BioSciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dtil#NASDAQ">DTIL</a>) fell 31.7% to $12.62 after the company announced a $40 million offering of common stock and warrants.</li>
<li>Volcon, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vlcn#NASDAQ">VLCN</a>) fell 30.1% to $0.93.</li>
<li>Tritium DCFC Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dcfc#NASDAQ">DCFC</a>) fell 27.4% to $0.1031.</li>
<li>Vivani Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vani#NASDAQ">VANI</a>) declined 27% to $3.0798. Vivani Medical announced pricing of $15 million registered direct offering of common stock and warrants.</li>
<li>Humacyte, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/huma#NASDAQ">HUMA</a>) shares dipped 25.3% to $3.2450. Humacyte priced its $40.2 million public offering of 13.4 million common stock at $3 per share.</li>
<li>New York Community Bancorp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nycb#NASDAQ">NYCB</a>) fell 24.2% to $3.6301 after the company identified material weakness in internal controls and announced a leadership transition.</li>
<li>JAKKS Pacific, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jakk#NASDAQ">JAKK</a>) fell 23.7% to $26.79 following weak quarterly results.</li>
<li>TTEC Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttec#NASDAQ">TTEC</a>) dipped 22.6% to $13.50 after the company reported mixed fourth-quarter financial results and issued FY24 adjusted EPS and revenue guidance below estimates.</li>
<li>Gritstone bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grts#NASDAQ">GRTS</a>) fell 20.5% to $2.2250 after the company announced an approximately 40% reduction of its workforce.</li>
<li>NCR Voyix Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vyx#NYSE">VYX</a>) declined 19.8% to $11.72. NCR Voyix said it sees preliminary FY23 revenue of $3.830 billion.</li>
<li>Cue Health Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hlth#NASDAQ">HLTH</a>) shares fell 15.6% to $0.2699. Cue Health has received a decision to grant European patent number EP3191849 titled &quot;Systems and Methods for Detection and Quantification of Analytes.&quot;</li>
<li>P10, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/px#NYSE">PX</a>) fell 15.2% to $7.86 following fourth-quarter results.</li>
<li>Elastic N.V. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/estc#NYSE">ESTC</a>) shares dipped 14.1% to $114.91 after the company reported third-quarter financial results.</li>
<li>American Coastal Insurance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acic#NASDAQ">ACIC</a>) fell 13.1% to $12.11 following weak sales.</li>
<li>B. Riley Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rily#NASDAQ">RILY</a>) shares declined 12.5% to $15.96 after the company reported fourth-quarter financial results and announced it has launched a review of strategic alternatives for its Appraisal and Valuation Services, and Retail, Wholesale &amp; Industrial Solutions businesses.</li>
<li>SoundHound AI, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/soun#NASDAQ">SOUN</a>) shares fell 11.6% to $6.56 after the company reported weaker-than-expected fourth-quarter financial results.</li>
<li>Senseonics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sens#NASDAQ">SENS</a>) fell 10.1% to $0.6311 following fourth-quarter results.</li>
<li>Ginkgo Bioworks Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dna#NYSE">DNA</a>) fell 9.7% to $1.3715 after the company reported worse-than-expected fourth-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>Ginkgo Bioworks Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dna#NYSE">DNA</a>) fell 9.5% to $1.3750 following downbeat quarterly results.</li>
<li>Xcel Energy Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xel#NASDAQ">XEL</a>) fell 6.4% to $49.29.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37414137/jim-cramer-says-this-is-a-smart-consulting-company-calls-commercial-metals-company-a-win"> Jim Cramer Says This Is A &#39;Smart Consulting Company,&#39; Calls Commercial Metals Company A Winner</a>

Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday.
Shares of The Cooper Companies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/coo#NYSE">COO</a>) rose sharply during Friday&rsquo;s session after the company reported better-than-expected first-quarter <a href="https://www.benzinga.com/quote/COO/earnings">financial results and raised guidance</a>.
Cooper Companies posted adjusted earnings of 85 cents per share, beating market estimates of 78 cents per share. The company&rsquo;s quarterly sales came in at $931.60 million versus expectations of $915.94 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
The Cooper Companies shares rose 7.4% to $100.61 on Friday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Dell Technologies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dell#NYSE">DELL</a>) jumped 26.3% to $119.52 as the company reported better-than-expected fourth-quarter financial results and increased its annual cash dividend by 20%.</li>
<li>Sweetgreen, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sg#NYSE">SG</a>) rose 26% to $16.05 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Everbridge, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evbg#NASDAQ">EVBG</a>) climbed 24.5% to $35.19 after it amended and restated the previously announced merger agreement with Thoma Bravo.</li>
<li>NetApp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntap#NASDAQ">NTAP</a>) shares rose 24.4% to $110.85 after the company reported better-than-expected third-quarter financial results and issued guidance.</li>
<li>Xponential Fitness, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xpof#NYSE">XPOF</a>) surged 24% to $12.50 following strong quarterly sales.</li>
<li>Opera Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opra#NASDAQ">OPRA</a>) rose 18.8% to $14.47 following strong sales.</li>
<li>REGENXBIO Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgnx#NASDAQ">RGNX</a>) rose 18.5% to $20.66.</li>
<li>RadNet, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdnt#NASDAQ">RDNT</a>) gained 18.1% to $44.71 following strong quarterly results.</li>
<li>Sana Biotechnology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sana#NASDAQ">SANA</a>) gained 17.3% to $11.78 after the company reported a year-over-year increase in fourth-quarter financial results.</li>
<li>Tidewater Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tdw#NYSE">TDW</a>) rose 15.3% to $80.73 following fourth-quarter financial results.</li>
<li>Y-mAbs Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ymab#NASDAQ">YMAB</a>) climbed 14.3% to $19.09 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Repay Holdings Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rpay#NASDAQ">RPAY</a>) gained 14.4% to $9.94 following upbeat quarterly results.</li>
<li>Root, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/root#NASDAQ">ROOT</a>) climbed 14.2% to $36.66. Jefferies analyst Yaron Kinar upgraded Root from Hold to Buy and raised the price target from $10 to $40.</li>
<li>Crinetics Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crnx#NASDAQ">CRNX</a>) gained 12.1% to $45.91 following quarterly results.</li>
<li>MasTec, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mtz#NYSE">MTZ</a>) gained 11.2% to $83.89 following strong quarterly results.</li>
<li>PTC Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ptct#NASDAQ">PTCT</a>) rose 10.4% to $31.11 following quarterly results.</li>
<li>Rambus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rmbs#NASDAQ">RMBS</a>) climbed 9.3% to $64.76. Rambus initiated accelerated share repurchase program to repurchase an aggregate of $50 million of its common stock.</li>
<li>Arrowhead Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arwr#NASDAQ">ARWR</a>) rose 9.3% to $35.10.</li>
<li>Lotus Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lot#NASDAQ">LOT</a>) gained 9.3% to $8.13.</li>
<li>Transocean Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rig#NYSE">RIG</a>) climbed 9.3% to $5.12.</li>
<li>Arvinas, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arvn#NASDAQ">ARVN</a>) gained 9.2% to $50.21. Barclays analyst Peter Lawson maintained Arvinas with an Overweight and raised the price target from $26 to $60.</li>
<li>Celldex Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cldx#NASDAQ">CLDX</a>) climbed 8.7% to $52.27. Celldex Therapeutics priced upsized $400 million public offering of 8.52 million common stock at $47 per share.</li>
<li>Dyne Therapeutics, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dyn#NYSE">DYN</a>) gained 7.9% to $29.03.</li>
<li>Celestica Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cls#NYSE">CLS</a>) rose 7.7% to $45.81.</li>
<li>MoonLake Immunotherapeutics (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mltx#NASDAQ">MLTX</a>) gained 6.6% to $51.40. Needham analyst Serge Belanger reiterated MoonLake with a Buy and maintained a $66 price target.</li>
<li>Super Micro Computer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) rose 6.3% to $921.40.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/03/37422012/bitcoin-ethereum-move-lower-sats-mantle-among-top-losers"> Bitcoin, Ethereum Move Lower; SATS, Mantle Among Top Losers</a>

ARWR

CLDX

CRNX

MLTX

PTCT

SMCI

Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday

JP Morgan analyst Robbie Marcus maintains Cooper Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>) with a Neutral and raises the price target from $94 to $100.

JP Morgan Maintains Neutral on Cooper Companies, Raises Price Target to $100

Piper Sandler analyst Jason Bednar maintains Cooper Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>) with a Overweight and raises the price target from $110 to $115.

Piper Sandler Maintains Overweight on Cooper Companies, Raises Price Target to $115

Stifel analyst Jonathan Block reiterates Cooper Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>) with a Buy and raises the price target from $105 to $110.

Reiteration

Stifel Reiterates Buy on Cooper Companies, Raises Price Target to $110

CooperCompanies shares are trading higher after the company reported better-than-expected Q1 financial results and raised guidance.

Mizuho analyst Anthony Petrone maintains Cooper Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>) with a Buy and raises the price target from $102.5 to $115.

Mizuho Maintains Buy on Cooper Companies, Raises Price Target to $115

Stocks look jaded after their record run, with the stock futures pointing to a modestly lower opening in the week&#8217;s final trading session. Given the recent gains, some consolidation can be expected before traders plot their next move. Analysts have been sounding out optimism over the broadening of the market rally as <a href="https://www.benzinga.com/money/best-small-cap-stocks">small-cap stocks join the party.</a>
Specifically, on Friday, traders could stay focused on a slew of Fed speeches, trying to read between the lines and draw cues regarding what the central bank could do at the March meeting. A couple of manufacturing activity data and a consumer sentiment reading may also be on investors&#8217; radar. Bond yields dipped as traders reassessed their rate-cut odds after the inflation data.
Cues From Thursday&#8217;s Trading Session
U.S. stocks advanced on Thursday as the Fed&#8217;s preferred inflation gauge &#8211; the core personal consumption expenditure index aligned with expectations. The mixed earnings news flow also dictated market sentiment. 
The major indices opened higher, encouraged by the inflation component of the January personal income and spending report. But the optimism tempered through the morning, with the Dow Industrials trading mostly below the unchanged line. The 30-stock blue-chip average moved decisively above the unchanged in the final hour of trading as it snapped a three-session losing streak. Yet it closed off its all-time highs. 
The Nasdaq Composite and the S&amp;P 500 Index returned their gains and briefly dipped below the unchanged line in the mid-session before recovering and taking off in the afternoon. Both averages ended in unchartered territory, with the former scaling its previous closing high of 16,057.44 set on Nov. 19, 2021.
Eight of the 11 S&amp;P 500 sectors closed in the green, with communication services, consumer discretionary, IT, material, and real estate stocks leading from the front. On the other hand, consumer staple and healthcare stocks fell sharply, and financial stocks closed with a slight negative bias.
Small-caps rebounded from their previous session&#8217;s losses. After trading solidly higher in early trading, they gave back much of their gains over the course of the session and yet closed moderately higher.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>+0.90%</td>
<td>16,091.92</td>
</tr>
<tr>
<td>S&amp;P 500 Index</td>
<td>+0.52%</td>
<td>5,096.27</td>
</tr>
<tr>
<td>Dow Industrials</td>
<td>+0.12%</td>
<td>38,996.39</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>+0.71%</td>
<td>2,054.84</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption"> Analyst Color:</figcaption></figure>
The S&amp;P 500 Index has acquitted itself creditably and is now trading well above the level it was it before the Fed began hiking rates in March 2022, said Creative Planning Chief Market Strategist Charlie Bilello.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The S&amp;P 500 is now 17% higher than where it was when the Fed started hiking rates in March 2022. <a href="https://twitter.com/search?q=%24SPX&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$SPX</a> <a href="https://t.co/K63lB9iDqv">pic.twitter.com/K63lB9iDqv</a>
&mdash; Charlie Bilello (@charliebilello) <a href="https://twitter.com/charliebilello/status/1763327043750773015?ref_src=twsrc%5Etfw">February 29, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Carol Schleif, Chief Investment Officer at BMO Family Office, expressed optimism regarding the broadening of the market rally. In an interview with CNBC, the analyst <a href="https://twitter.com/LastCallCNBC/status/1763358129847185435">said,</a> &#8220;It is positive that you're seeing a broadening out of all the market indexes away from just that Magnificent 7.&#8221; When the Fed starts cutting rates, most small-caps, most of which are debt-laden, will begin to move primarily on what their business plans, she said.
Futures Today Futures Performance On Friday ( as of 6 a.m. ET)
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Performance (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.23%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.24%</td>
</tr>
<tr>
<td>Dow</td>
<td>-0.35%</td>
</tr>
<tr>
<td>R2K</td>
<td>+0.12%</td>
</tr>
</tbody>
</table>
</figure>
<a href="https://www.benzinga.com/premarket/">In premarket trading</a> on Friday, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) slipped 0.27% to $504.90 and the Invesco QQQ ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) fell 0.20% to $434.40, according to <a href="https://benzinga.grsm.io/lxquj26b2sag">Benzinga Pro data.</a>
Upcoming Economic Data:
The Fed speeches scheduled for Friday include:
<ul>
<li>Richmond Fed President Thomas Barkin makes a TV appearance: 8:30 a.m. ET</li>
<li>Chicago Fed President Austan Goolsbee makes a TV appearance: 10 a.m. ET</li>
<li>Fed Governor Christopher Waller: 10:15 a.m. ET</li>
<li>Dallas Fed President Lorie Logan: 10:15 a.m. ET</li>
<li>Atlanta Fed President Raphael Bostic: 12:15 p.m. ET</li>
<li>San Francisco Fed President Mary Daly: 1:30 p.m. ET</li>
<li>Fed Governor Adriana Kugler: 3:30 p.m. ET</li>
</ul>
S&amp;P Global will release the final U.S. manufacturing purchasing managers&#8217; index at 9:45 a.m. ET, with the flash reading released earlier this month coming in at 51.5 for February, up from 50.7 in January.
The Institute of Supply Management&#8217;s manufacturing PMI is due at 10 a.m. ET is expected to edge up from 49.1 in January to 49.5 in February. 
The University of Michigan&#8217;s final consumer sentiment index for February will likely be left unrevised at the flash reading of 79.6 compared to 79 in January. Traders may also look forward to inflation expectations readings from the report.
The Commerce Department is due to release its construction spending report for January at 10 a.m. ET. Economists, on average, expect construction spending to increase 0.2% month-over-month, slower than the 0.9% increase in December.
See also: <a href="https://www.benzinga.com/money/best-futures-trading-software">Best Futures Trading Software</a>
Stocks In Focus:
<ul>
<li>NetApp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTAP#NASDAQ">NTAP</a>) climbed over 16.50%<a href="https://www.benzinga.com/premarket"> in premarket trading </a>following its earnings announcement.</li>
<li>Other stocks moving on earnings include Autodesk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) (nearly 9%), Cooper Companies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>) (nearly 7%), Fisker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSR#NYSE">FSR</a>) (down about 40%), Zscaler, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) (down about 7%), Hewlett Packard Enterprises Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>) (down over 6%), and SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUND#NASDAQ">SOUND</a>) (down about 20%).</li>
<li>Plug Power, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) and EchoStar Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATS#NASDAQ">SATS</a>) are among the major names <a href="https://www.benzinga.com/calendars/earnings">scheduled to release their quarterly results ahead of the market open.</a></li>
<li>Chinese electric-vehicle startup Li Auto, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) fell about 2.70%, while peers XPeng, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NASDAQ">XPEV</a>) and Nio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NASDAQ">NIO</a>) rose over 2% and 1%, respectively, after the release of February deliveries numbers.</li>
</ul>
Commodities, Bonds, Other Global Equity Markets:
Crude oil futures rose 1.06% to $79.09 in early European session on Friday after the commodity fell 0.36% on Thursday. The yield on the benchmark 10-year Treasury note fell 0.023 percentage points at 4.229%. 
Most Asian markets advanced on Friday, led by the Japanese and Indian markets. The positive sentiment on Wall Street overnight proved contagious, generating strength in the domestic markets. The Indonesian, Singaporean, and Taiwanese markets clocked modest losses, while the South Korean market remained closed for a public holiday.
European stocks were mixed in early trading on Friday.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is having an off day on Friday, as it has pulled back from the $63,000+ level it traded in the previous session.
Read Next:<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37414352/wall-streets-dean-of-valuation-thinks-youre-setting-yourself-up-to-lose-with-nvidia"> Wall Street&#8217;s &#8216;Dean Of Valuation&#8217; Thinks &#8216;You&#8217;re Setting Yourself Up To Lose&#8217; With Nvidia By Playing &#8216;The Plausible Game&#8217; — Says This Is What Investors Need To Ask Before Getting In</a>

Futures

Previews

Economics

Pre-Market Outlook

$BTC

ADSK

PLUG

SATS

SOUND

XPEV

US Stocks Poised For Consolidation Ahead Of Fed-Speech Deluge, While Bitcoin Pulls Back From $63K Level: Analyst Bullish On Broadening Rally

CooperCompanies adopted a four-for-one stock split that became effective on Friday, February 16, 2024, at 5:00 PM ET, and began trading on a stock split-adjusted basis at market open on Tuesday, February 20, 2024. The company&#39;s prior&nbsp;Fiscal 2024 non-GAAP diluted earnings per share outlook was&nbsp;$13.60-$14.00.

Guidance

CooperCompanies Raises FY24 Total Revenue Forecast From $3.809B-$3.877B To $3.847B-$3.897B (Est $3.847B), Adj EPS To $3.50-$3.58 (Est $3.46)

CooperCompanies shares are trading higher after the company reported better-than-expected Q1 financial results.

Cooper Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COO#NYSE">COO</a>) reported quarterly Adj earnings of $0.85 per share which beat the analyst consensus estimate of $0.78 by 8.97 percent.&nbsp;The company reported quarterly sales of $931.60 million which beat the analyst consensus estimate of $915.94 million by 1.71 percent. This is a 8.51 percent increase over sales of $858.50 million the same period last year.

Cooper Companies Q1 Adj EPS $0.85 Beats $0.78 Estimate, Sales $931.60M Beat $915.94M Estimate

Cooper Companies upgraded at J.P. Morgan on outlook

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Allakos (ALLK – Research Report), Century Therapeuti...

Analysts Are Bullish on These Healthcare Stocks: Allakos (ALLK), Century Therapeutics (IPSC)

A rating of 81 puts Cooper Companies Inc (COO) near the top of the Medical Instruments and Supplies industry according to InvestorsObserver. Cooper Companies Inc's score of 81 means it scores higher than 81% of stocks in the industry. Cooper Companies Inc also received an overall rating of 56, putting it above 56% of all s

Is Cooper Companies Inc (COO) a Good Buy in the Medical Instruments & Supplies Industry?

The Cooper Companies: Rating Upgrade As Near-Term Momentum Should Continue

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Cooper Co (COO – Research Report), with a price target ...

Buy Rating Affirmed for Cooper Companies, Inc. on Optimistic FY2024 Outlook and Strategic Market Positioning

Cooper Companies Inc (COO) receives a weak  valuation ranking of 35 from InvestorsObserver data analysis. The proprietary ranking system focuses on the underlying health of a company through analysis of its stock price, earnings, and growth rate. COO has a better value than 35% of stocks based on these valuation analytics.

Should You Buy Cooper Companies Inc (COO) Stock Tuesday?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Several times over the past few years, I&rsquo;ve referred to the 2-for-1 Index and the 2-for-1 newsletter, a monthly publication dedicated to stock split plays for 2024 and beyond.&nbsp;



Neil Macneale III, a retired general contractor from Northern California, runs the newsletter and index. I&rsquo;ve kept in contact with Macneale over the years because his portfolio has delivered <a href="https://2-for-1.com/about/">consistent, above-average returns</a> by buying and selling a single stock each month.&nbsp;



Macneale has published the newsletter since Aug. 1996. Its annual return over 27.5 years through Dec. 31, 2023, is <a href="https://2-for-1.com/track-record/">12.07%</a>, 248 basis points higher than the Wilshire 5000 Total Market Full Cap Total Return Index.



Could you do better with other indexes? Sure, you could, but I would bet dollars to donuts that its risk-adjusted returns are some of the best you&rsquo;ll find with so little work involved.



In recent years, it&rsquo;s been tougher to find quality companies splitting their stock&mdash;typically at least 2-for-1, hence the name. However, Macneale&rsquo;s managed to cobble together a portfolio of 28-30 stocks despite the challenge.



Here are three names from the 2-for-1&rsquo;s <a href="https://mailchi.mp/cdccd3500a33/2-for-1stocksplits-9365954?e=c707ccfdb8">latest newsletter</a>.&nbsp;



<h2>Cooper Companies (COO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/04/contact-lens-1600-300x169.jpg" alt="Young woman putting contact lens in her right eye, close up"><div>Source: life-literacy via Shutterstock</div></div>Cooper Companies (NASDAQ:<a href="https://investorplace.com/stock-quotes/coo-stock-quote/">COO</a>) is one of the newsletter&rsquo;s most recent additions. It was added on March 18, 2024, after the contact lens manufacturer completed a 4:1 stock split on <a href="https://www.stocktitan.net/news/COO/cooper-companies-4-for-1-stock-split-effective-friday-2-yz2jd1kofhey.html#:~:text=CooperCompanies%20(COO)%20announces%20a%20four,by%20the%20board%20of%20directors.">Feb. 16</a>.&nbsp;&nbsp;




&ldquo;COO&rsquo;s PE ratio is quite high but its price-to-book ratio is well below industry averages. It pays a small dividend and has an average measure of volatility. Like ODFL, Cooper also has a record of strong earnings growth at close to 27% per year over the last five years,&rdquo; Macneale <a href="https://mailchi.mp/cdccd3500a33/2-for-1stocksplits-9365954?e=c707ccfdb8">wrote</a> on March 15.&nbsp;&nbsp;




Old Dominion Freight Line (NASDAQ:<a href="https://investorplace.com/stock-quotes/odfl-stock-quote/">ODFL</a>) is Macneale&rsquo;s second pick. That gets the portfolio to 29 stocks, one shy of its ideal number of holdings.



I can&rsquo;t remember if I&rsquo;ve ever recommended Cooper stock. I&rsquo;ve always liked the dual nature of its business, with specialty contact lenses (CooperVision) as one part and fertility and women&rsquo;s health services through CooperSurgical as the other.&nbsp;



CooperVision manufactures <a href="https://www.coopercos.com/coopervision/">billions of contact lenses</a> yearly, selling its products in more than 130 countries. It had <a href="https://investor.coopercos.com/static-files/6f9566b8-01ce-4d7f-8879-edd33d4e242c">$2.42 billion</a> in revenue in 2023 and $587.7 million in operating income. CooperSurgical provides women and babies with over <a href="https://www.coopercos.com/coopersurgical/">600 products</a> from more than 100 locations worldwide. It had $1.17 billion in revenue in 2023 and an operating profit of $16.1 million.&nbsp;



In 2024, it expects to grow its revenues by <a href="https://investor.coopercos.com/news-releases/news-release-details/coopercompanies-announces-first-quarter-2024-results">8.5%</a> at the midpoint of its guidance, with adjusted EPS of $3.54.&nbsp;



It&rsquo;s quite the business.



<h2>Mueller Industries (MLI)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/copper1600-1-300x169.jpg" alt="Stacks of copper tubing"><div>Source: Shutterstock</div></div>Mueller Industries (NYSE:<a href="https://investorplace.com/stock-quotes/mli-stock-quote/">MLI</a>) was <a href="https://2-for-1.com/pdf/Oct%202023.pdf">added</a> on Oct. 16, 2023, after the company announced it would do a 2:1 split a week later.&nbsp;



Macneale had some very positive commentary about the copper pipe and fittings manufacturer.




&ldquo;Mueller Industries has been consistently profitable, has a rock-solid balance sheet, and can boast outstanding valuation numbers,&rdquo; Macneale wrote in the October 2023 newsletter edition.&nbsp;




Mueller is one of my favorite companies. I&rsquo;ve been <a href="https://investorplace.com/2022/09/7-small-company-stocks-you-should-own-now/">recommending</a> MLI stock since Sept. 2021. It&rsquo;s a great American success story.&nbsp;



I recently wrote about Mueller in January, <a href="https://investorplace.com/2024/01/3-cash-rich-stocks-to-buy-for-peace-of-mind-in-2024/">stating</a>, &ldquo;It&rsquo;s simply one of the best stocks you can own.&rdquo;



How much has it grown? In 1992, its annual operating income was $29.3 million. It was <a href="https://ir.muellerindustries.com/news/press-releases/detail/169/mueller-industries-inc-reports-fiscal-2023-fourth-quarter">$756.1 million</a> in 2023, 26 times the amount 30 years ago.



In Q4 2023, revenue decreased 17%, largely due to lower demand for new residential construction. With the U.S. housing market short as many as <a href="https://nypost.com/2024/02/28/real-estate/the-us-housing-supply-is-short-7-2-million-homes/">7.2 million</a> homes, construction will likely pick up once interest rates decrease.&nbsp;&nbsp;&nbsp;&nbsp;



Mueller will be okay.



<h2>Copart (CPRT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/02/auction-300x169.png" alt="Image of a hand holding a wooden hammer at an auction."><div>Source: Gena Melendrez / Shutterstock.com</div></div>Copart (NASDAQ:<a href="https://investorplace.com/stock-quotes/cprt-stock-quote/">CPRT</a>) was added in Aug. 2023 after the online used car auction company announced a <a href="https://2-for-1.com/pdf/Aug%202023.pdf">2:1 split</a>.




&ldquo;Copart has been in the 2 for 1 Index twice before, in 2012 and 2017. In both instances CPRT was a winner; in the second instance, spectacularly so,&rdquo; Macneale wrote in the August 2023 newsletter.&nbsp;



&ldquo;&hellip; No debt, highly profitable, growing at about 20% per year for the last five years &ndash; what&rsquo;s not to like? Insiders own a substantial percentage of this company and have obviously found a formula that benefits themselves and their shareholders.&rdquo;




Macneale is my kind of stockpicker. You can tell his focus on a company&rsquo;s margin of safety is paramount.



Last November, I suggested that Copart stock was overbought, arguing that its free cash flow yield of less than 2% made it an expensive buy. Boy, was I wrong? It&rsquo;s up 14% in the four months since.&nbsp;



However, I did say that the services it provides <a href="https://investorplace.com/2023/11/caution-these-3-stocks-are-overbought-after-the-november-rally/">insurance companies</a> won&rsquo;t go out of style, giving it a wide moat to keep generating 33% net margins.&nbsp;



As Macneale rightly asks, what&rsquo;s not to like?



On the date of publication, Will Ashworth did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/"> Publishing Guidelines</a>.
<div>Will Ashworth has written about investments full-time since 2008. Publications where he&rsquo;s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He particularly enjoys creating model portfolios that stand the test of time. He lives in Halifax, Nova Scotia.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/04/double-your-shares-double-your-gains-3-stock-split-plays-for-2024/">Double Your Shares, Double Your Gains: 3 Stock Split Plays for 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Double Your Shares, Double Your Gains: 3 Stock Split Plays for 2024

Analysts are highly bullish about Cooper Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>), an S&P 500 stock (SPX) from the MedTech space. Impressed by Cooper Companies' Q1 F...

Cooper Companies (NASDAQ:COO): Analysts Are Bullish on this MedTech S&P 500 Stock

New constituents of Goldman Sachs' ROE growth basket

Cooper Co (COO) just unveiled an update. The Cooper Companies, Inc. has entered into a significant multicurrency credit agreement on May 1, 2024, f...

Cooper Co Secures New $2.3 Billion Multicurrency Credit Facility

ADBE

ALLK

AMZN

CPRT

FOXA

INTC

IPSC

MDLZ

MPWR

ODFL

TRGP

TRMB

Management

Press Releases

CooperCompanies Appoints Lawrence E. Kurzius to Board of Directors

CooperCompanies Announces Fourth Quarter and Full Year 2023 Results

CooperCompanies Sets Annual Meeting And Stockholder Record Dates

Health Care

CooperCompanies to Present at the J.P. Morgan Healthcare Conference

CooperCompanies Announces Release Date for First Quarter 2024

Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cooper Companies Stock (NASDAQ:COO), Short Interest Report

People Also Watch